Efficient and accurate preoperative assessment of the right-sided heart structural complex (RSHSc) is crucial for planning transcatheter tricuspid valve replacement (TTVR). However, current manual methods remain time-consuming and inconsistent. To address this unmet clinical need, this study aimed to develop and validate TRI-PLAN, the first fully automated, deep learning (DL)-based framework for pre-TTVR assessment. A total of 140 preprocedural computed tomography angiography (CTA) scans (63,962 slices) from patients with severe tricuspid regurgitation (TR) at two high-volume cardiac centers in China were retrospectively included. The patients were divided into a training cohort (n = 100), an internal validation cohort (n = 20), and an external validation cohort (n = 20). TRI-PLAN was developed by a dual-stage right heart assessment network (DRA-Net) to segment the RSHSc and localize the tricuspid annulus (TA), followed by automated measurement of key anatomical parameters and right ventricular ejection fraction (RVEF). Performance was comprehensively evaluated in terms of accuracy, interobserver benchmark comparison, clinical usability, and workflow efficiency. TRI-PLAN achieved expert-level segmentation accuracy (volumetric Dice 0.952/0.955; surface Dice 0.934/0.940), precise localization (standard deviation 1.18/1.14 mm), excellent measurement agreement (ICC 0.984/0.979) and reliable RVEF evaluation (R = 0.97, bias<5 %) across internal and external cohorts. In addition, TRI-PLAN obtained a direct acceptance rate of 80 % and reduced total assessment time from 30 min manually to under 2 min (>95 % time saving). TRI-PLAN provides an accurate, efficient, and clinically applicable solution for pre-TTVR assessment, with strong potential to streamline TTVR planning and enhance procedural outcomes.

Integration of AI and XR in TAVR is revolutionizing the management of severe aortic stenosis by enhancing diagnostic accuracy, risk stratification, and pre-procedural planning. Advanced algorithms now facilitate precise electrocardiographic, echocardiographic, and CT-based assessments that reduce observer variability and enable patient-specific risk prediction. Immersive XR technologies, including augmented, virtual, and mixed reality, improve spatial visualization of complex cardiac anatomy and support real-time procedural guidance. Despite these advancements, standardized protocols, regulatory frameworks, and ethical safeguards remain necessary for widespread clinical adoption.

The REgistry of Flow and Perfusion Imaging for Artificial Intelligence with PET (REFINE PET) was established to collect multicenter PET and associated computed tomography (CT) images, together with clinical data and outcomes, into a comprehensive research resource. REFINE PET will enable validation and development of both standard and novel cardiac PET/CT processing methods. REFINE PET is a multicenter, international registry that contains both clinical and imaging data. The PET scans were processed using QPET software (Cedars-Sinai Medical Center, Los Angeles, CA), while the CT scans were processed using deep learning (DL) to detect coronary artery calcium (CAC). Patients were followed up for the occurrence of major adverse cardiovascular events (MACE), which include death, myocardial infarction, unstable angina, and late revascularization (>90 days from PET). The REFINE PET registry currently contains data for 35,588 patients from 14 sites, with additional patient data and sites anticipated. Comprehensive clinical data (including demographics, medical history, and stress test results) were integrated with more than 2200 imaging variables across 42 categories. The registry is poised to address a broad range of clinical questions, supported by correlating invasive angiography (within 6 months of MPI) in 5972 patients and a total of 9252 major adverse cardiovascular events during a median follow-up of 4.2 years. The REFINE PET registry leverages the integration of clinical, multimodality imaging, and novel quantitative and AI tools to advance the role of PET/CT MPI in diagnosis and risk stratification.

To evaluate the performance of artificial intelligence (AI)-based coronary artery calcium scoring (CACS) on non-electrocardiogram (ECG)-gated chest CT, using manual quantification as the reference standard, while characterizing per-vessel reliability and clinical risk classification impacts. Retrospective study of 290 patients (June 2023-2024) with paired non-ECG-gated chest CT and ECG-gated cardiac CT (median time was 2 days). AI-based CACS and manual CACS (CACS_man) were compared using intraclass correlation coefficient (ICC) and weighted Cohen's kappa (3,1). Error types, anatomical distributions, and CACS of the lesions of individual arteries or segments were assessed in accordance with the Society of Cardiovascular Computed Tomography (SCCT) guidelines. The total CACS of chest CT demonstrated excellent concordance with CACS_man (ICC = 0.87, 95 % CI 0.84-0.90). Non-ECG-gated chest showed a 7.5-fold increased risk misclassification rate compared to ECG-gated cardiac CT (41.4 % vs. 5.5 %), with 35.5 % overclassification and 5.9 % underclassification. Vessel-specific analysis revealed paradoxical reliability of the left anterior descending artery (LAD) due to stent misclassification in four cases (ICC = 0.93 on chest CT vs 0.82 on cardiac CT), while the right coronary artery (RCA) demonstrated suboptimal performance with ICCs ranging from 0.60 to 0.68. Chest CT exhibited higher false-positive (1.9 % vs 0.5 %) and false-negative rates (14.4 % vs 4.3 %). False positive mainly derived from image noise in proximal LAD/RCA (median CACS 5.97 vs 3.45) and anatomical error, while false negatives involved RCA microcalcifications (median CACS 2.64). AI-based non-ECG-gated chest CT demonstrates utility for opportunistic screening but requires protocol optimization to address vessel-specific limitations and mitigate 41.4 % risk misclassification rates.

BackgroundMyocarditis is a life-threatening disease with significant hemodynamic risks during the acute phase. Although histopathological examination of myocardial biopsy specimens remains the gold standard for diagnosis, there is no established method for objectively quantifying cardiomyocyte damage. We aimed to develop an AI model to evaluate clinical myocarditis severity using comprehensive pathology data. MethodsWe retrospectively analyzed 314 patients (1076 samples) who underwent myocardial biopsy from 2002 to 2021 at the National Cerebrovascular Center. Among these patients, 158 were diagnosed with myocarditis based on the Dallas criteria. A Multiple Instance Learning (MIL) model served as a pre-trained classifier to detect myocarditis across whole-slide images. We then constructed two clinical severity-prediction models: (1) a logistic regression model (Model 1) using the density of inflammatory cells per unit area, and (2) a Transformer-based model (Model 2), which processed the top-ranked patches identified by the MIL model to predict clinical severe outcomes. ResultsModel 1 achieved an AUROC of 0.809, indicating a robust association between inflammatory cell density and severe myocarditis. In contrast, Model 2, the Transformer-based approach, yielded an AUROC of 0.993 and demonstrated higher accuracy and precision for severity prediction. Attention score visualizations showed that Model 2 captured both inflammatory cell infiltration and additional morphological features. These findings suggest that combining MIL with Transformer architectures enables more comprehensive identification of key histological markers associated with clinical severe disease. ConclusionsOur results highlight that a Transformer-based AI model analyzing whole-slide pathology images can accurately assess clinical myocarditis severity. Moreover, simply quantifying the extent of inflammatory cell infiltration also correlates strongly with clinical outcomes. These methods offer a promising avenue for improving diagnostic precision, guiding treatment decisions, and ultimately enhancing patient management. Future prospective studies are warranted to validate these models in broader clinical settings and facilitate their integration into routine pathological workflows. What is new?- This is the first study to apply an AI model for the diagnosis and severity assessment of myocarditis. - New evidence shows that inflammatory cell infiltration is related to the severity of myocarditis. - Using information from the entire tissue, not just inflammatory cells, allows for a more accurate assessment of myocarditis severity. What are the clinical implications?- The use of the AI model allows for an unprecedented histological evaluation of myocarditis severity, which can enhance early diagnosis and intervention strategies. - Rapid and precise assessments of myocarditis severity by the AI model can support clinicians in making timely and appropriate treatment decisions, potentially improving patient outcomes. - The incorporation of this AI model into clinical practice may streamline diagnostic workflows and optimize the allocation of medical resources, enhancing overall patient care.

Cardiovascular diseases are the leading cause of death in the world, with coronary artery disease being the most prevalent. Coronary artery calcifications are critical biomarkers for cardiovascular disease, and their quantification via non-contrast computed tomography is a widely accepted and heavily employed technique for risk assessment. Manual segmentation of these calcifications is a time-consuming task, subject to variability. State-of-the-art methods often employ convolutional neural networks for an automated approach. However, there is a lack of studies that perform these segmentations with 3D architectures that can gather important and necessary anatomical context to distinguish the different coronary arteries. This paper proposes a novel and automated approach that uses a lightweight three-dimensional convolutional neural network to perform efficient and accurate segmentations and calcium scoring. Results show that this method achieves Dice score coefficients of 0.93 ± 0.02, 0.93 ± 0.03, 0.84 ± 0.02, 0.63 ± 0.06 and 0.89 ± 0.03 for the foreground, left anterior descending artery (LAD), left circumflex artery (LCX), left main artery (LM) and right coronary artery (RCA) calcifications, respectively, outperforming other state-of-the-art architectures. An external cohort validation also showed the generalization of this method's performance and how it can be applied in different clinical scenarios. In conclusion, the proposed lightweight 3D convolutional neural network demonstrates high efficiency and accuracy, outperforming state-of-the-art methods and showcasing robust generalization potential.

In order to automate the centerline extraction of the coronary tree, three challenges must be addressed: tracking branches automatically, passing through plaques successfully, and detecting endpoints accurately. This study aims to develop a method to solve the three challenges. We propose a branch-endpoint-aware coronary centerline extraction framework. The framework consists of a deep reinforcement learning-based tracker and a 3D dilated CNN-based detector. The tracker is designed to predict the actions of an agent with the objective of tracking the centerline. The detector identifies bifurcation points and endpoints, assisting the tracker in tracking branches and terminating the tracking process automatically. The detector can also estimate the radius values of the coronary artery. The method achieves the state-of-the-art performance in both the centerline extraction and radius estimate. Furthermore, the method necessitates minimal user interaction to extract a coronary tree, a feature that surpasses other interactive methods. The method can track branches automatically, pass through plaques successfully and detect endpoints accurately. Compared with other interactive methods that require multiple seeds, our method only needs one seed to extract the entire coronary tree.

Noninvasive cardiac testing with coronary computed tomography angiography (CCTA) and single-photon emission computed tomography (SPECT) are becoming alternatives to invasive angiography for the evaluation of obstructive coronary artery disease. We aimed to evaluate whether a novel artificial intelligence (AI)-assisted CCTA program is comparable to SPECT imaging for ischemic testing. CCTA images were analyzed using an artificial intelligence convolutional neural network machine-learning-based model, atherosclerosis imaging-quantitative computed tomography (AI-QCT) ISCHEMIA . A total of 183 patients (75 females and 108 males, with an average age of 60.8 years ± 12.3 years) were selected. All patients underwent AI-QCT ISCHEMIA -augmented CCTA, with 60 undergoing concurrent SPECT and 16 having invasive coronary angiograms. Eight studies were excluded from analysis due to incomplete data or coronary anomalies.  A total of 175 patients (95%) had CCTA performed, deemed acceptable for AI-QCT ISCHEMIA interpretation. Compared to invasive angiography, AI-QCT ISCHEMIA -driven CCTA showed a sensitivity of 75% and specificity of 70% for predicting coronary ischemia, versus 70% and 53%, respectively for SPECT. The negative predictive value was high for female patients when using AI-QCT ISCHEMIA compared to SPECT (91% vs. 68%, P  = 0.042). Area under the receiver operating characteristic curves were similar between both modalities (0.81 for AI-CCTA, 0.75 for SPECT, P  = 0.526). When comparing both modalities, the correlation coefficient was r  = 0.71 ( P  < 0.04). AI-powered CCTA is a viable alternative to SPECT for detecting myocardial ischemia in patients with low- to intermediate-risk coronary artery disease, with significant positive and negative correlation in results. For patients who underwent confirmatory invasive angiography, the results of AI-CCTA and SPECT imaging were comparable. Future research focusing on prospective studies involving larger and more diverse patient populations is warranted to further investigate the benefits offered by AI-driven CCTA.

Coronary CT angiography is widely implemented, with an estimated 2.2 million procedures in patients with stable chest pain every year in Europe alone. In parallel, artificial intelligence and machine learning are poised to transform coronary atherosclerotic plaque evaluation by improving reliability and speed. However, little is known about how to use coronary atherosclerosis imaging biomarkers to individualize recommendations for medical treatment. This Consensus Statement from the Quantitative Cardiovascular Imaging (QCI) Study Group outlines key recommendations derived from a three-step Delphi process that took place after the third international QCI Study Group meeting in September 2024. Experts from various fields of cardiovascular imaging agreed on the use of age-adjusted and gender-adjusted percentile curves, based on coronary plaque data from the DISCHARGE and SCOT-HEART trials. Two key issues were addressed: the need to harness the reliability and precision of artificial intelligence and machine learning tools and to tailor treatment on the basis of individualized plaque analysis. The QCI Study Group recommends that the presence of any atherosclerotic plaque should lead to a recommendation of pharmacological treatment, whereas the 70th percentile of total plaque volume warrants high-intensity treatment. The aim of these recommendations is to lay the groundwork for future trials and to unlock the potential of coronary CT angiography to improve patient outcomes globally.